ZNF886P

Across TCGA pan-cancer cohorts, ZNF886P RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated ZNF886P data layer.

The strongest signal is observed in testicular germ cell tumors (TGCT), where higher ZNF886P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ZNF886P expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

TGCT, UCEC, and SKCM are the cancer types where ZNF886P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
TGCT	DFS	Tertile	II,III,IV	0.015	0.919	<.001	54	view →
UCEC	OS	Tertile	III,IV	0.054	0.592	<.001	54	view →
SKCM	OS	Tertile	IV	0.179	0.755	<.001	21	view →
THYM	DFS	Tertile	II,III,IV	0.075	0.851	<.001	18	view →
HNSC	DFS	Tertile	IV	0.050	0.570	<.001	18	view →
LIHC	OS	Tertile	All	0.420	0.785	.004	18	view →
STAD	OS	Tertile	All	0.142	0.730	<.001	18	view →
ESCA	OS	Tertile	III,IV	0.692	0.367	.042	12	view →
LGG	DFS	Tertile	All	0.459	0.742	.022	12	view →
LUSC	OS	Tertile	All	0.196	0.659	.049	9	view →
KIRC	OS	Tertile	All	0.689	0.816	.047	3	view →
KIRP	OS	Tertile	All	0.761	0.950	.031	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

ZNF886P–TGCT (DFS)

Open the TGCT breakdown →